Locations
England, UK · Oxford, UK · Oxfordshire, UK
industry
Biotechnology
Size
1 - 10 employees
Stage
Series A
founded in
2015
Oxford Endovascular is a spin-out from Oxford University developing technology to prevent brain haemorrhage. Oxiflow™ is a novel, next-generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture. Competitors have adverse events related to poor placement of devices due to their inherent design weaknesses. Oxiflow™ is a unique design that places more accurately and safely than existing products, reducing the risk of complications and conforming to blood vessel shapes, making more patients treatable. Patented in Europe, the U.S., China, and Japan. Created by world experts in the field, Oxiflow™ has gone through proof of concept pre-clinical studies that will be followed by a first in human study en route to gaining FDA and CE mark.
Something looks off?On-site & Remote